未登录

J

Jorge Jacinto

centro de medicina de reabilitacao de alcoitao

H指数:17

被引数:1,190

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Active Function Improvement with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study

重复注射肉毒毒素A改善上肢痉挛的主动功能：ULIS-III研究的纵向分析

IF4

2026-10-030

OA

Longitudinal, Multi-Cycle Evaluation of Passive Function Improvement in People with Arm Spasticity Treated with Botulinum Toxin A

IF4

2026-01-190

OAAI

Pathways for Diagnosis and Multimodal Management, Including Botulinum Neurotoxin Therapy, in Shoulder Conditions Following Acquired Central Nervous System Lesions

肩部继发性中枢神经系统损伤的诊断与多模式管理路径，包括肉毒毒素神经毒素治疗

Toxins 2025, Vol. 17, Page 385

IF4

2025-08-200

PRE

Pain Reduction with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study

上肢痉挛时反复注射肉毒杆菌毒素A可减轻疼痛: 来自ULIS-III研究的纵向分析

IF4

2025-03-010

OAAI

MUSCLE SELECTION AND DOSING IN PATIENTS UNDERGOING TREATMENT WITH ABOBOTULINUMTOXINA FOR LOWER LIMB SPASTICITY IN REAL-WORLD PRACTICE

肌肉选择和剂量在真实世界实践中接受ABOBOULINUMTOXINA治疗下肢痉挛患者的应用

JOURNAL OF REHABILITATION MEDICINE

IF2.3

2025-02-070

OA

Initial Contact with Forefoot or Rearfoot in Spastic Patients After Stroke-Three-Dimensional Gait Analysis

NEUROLOGY INTERNATIONAL

IF3

2025-01-180

OAAI

Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2023-12-010

PRE

Outcome measurement and goal-setting recommendations in the multipattern treatment of shoulder spasticity with botulinum neurotoxin

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2023-12-010

PRE

Selecting Goals and Target Muscles for Botulinum Toxin A Injection Using the Goal Oriented Facilitated Approach to Spasticity Treatment (GO-FAST) Tool

IF4

2023-11-297

OAAI

Leg Activity Measure (LegA) sensitivity to change following treatment of lower limb spasticity with a single cycle of abobotulinumtoxinA in an ambulant population

IF8.5

2023-04-250

PRE

Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic

IF4

2021-08-223

OAAI

OrthoRehab: Development of a New Methodology for the Comparison Study Between Different Types of Ankle-Foot Orthoses in Foot Dysfunction

OrthoRehab: 开发一种新方法，用于比较不同类型的踝足矫形器在足部功能障碍中的比较研究

FRONTIERS IN DIGITAL HEALTH

IF3.8

2021-01-260

OAAI

Velocity Determinants in Spastic Patients after Stroke-A Gait Analysis Study

NEUROLOGY INTERNATIONAL

IF3

2020-11-065

OAAI

The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician's view

ANNALS OF PHYSICAL AND REHABILITATION MEDICINE

IF4.6

2020-11-0182

OAAI

COVID-19 pandemic. What should Physical and Rehabilitation Medicine specialists do? A clinician's perspective

EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE

IF3.4

2020-09-0186

PRE

Management of Spastic Paresis and Cervical Dystonia: Access to Therapeutic Innovations Through an International Program of Practical Courses

CLINICAL THERAPEUTICS

IF3.6

2019-11-015

OAAI

Design and development of a customised knee positioning orthosis using low cost 3D printers

VIRTUAL AND PHYSICAL PROTOTYPING

IF8.8

2017-08-0228

PREAI

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)

IF2.3

2016-06-1726

OAAI

Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study

IF4

2015-04-0822

OAAI

PATIENT-CENTERED OUTCOMES IN UPPER LIMB SPASTICITY: RESULTS FROM A LARGE INTERNATIONAL COHORT STUDY (ULIS-2)

VALUE IN HEALTH

IF6

2013-11-010

OAAI